Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

DEXI antibody (AA 1-95)

DEXI Reactivity: Human ELISA, IHC Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7149836
  • Target See all DEXI Antibodies
    DEXI (Dexamethasone-Induced Transcript (DEXI))
    Binding Specificity
    • 15
    • 8
    • 7
    • 6
    • 5
    AA 1-95
    Reactivity
    • 24
    • 20
    • 1
    Human
    Host
    • 35
    Rabbit
    Clonality
    • 35
    Polyclonal
    Conjugate
    • 7
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This DEXI antibody is un-conjugated
    Application
    • 19
    • 15
    • 13
    • 13
    • 3
    • 3
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC)
    Cross-Reactivity
    Human
    Purification
    Antigen Affinity Purified
    Immunogen
    Recombinant Human Dexamethasone-induced protein (1-95AA)
    Isotype
    IgG
  • Application Notes
    Recommended dilution: IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    DEXI (Dexamethasone-Induced Transcript (DEXI))
    Alternative Name
    DEXI (DEXI Products)
    Synonyms
    1810029J14Rik antibody, AI836170 antibody, AW413143 antibody, D16Bwg0586e antibody, Myle antibody, MYLE antibody, RGD1564938 antibody, zgc:101082 antibody, dexamethasone-induced transcript antibody, Dexi homolog antibody, Dexi homolog (mouse) antibody, Dexi antibody, DEXI antibody, dexi antibody
    Background
    DEXI antibody, MYLEDexamethasone-induced protein antibody, Protein MYLE antibody
    UniProt
    O95424
You are here: